Market research
PI6.F Pieris Pharmaceuticals, Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the PI6.F discussion.
5 years, 5 months ago
Pieris Pharmaceuticals, Inc is currently in a long term uptrend where the price is trading 31.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Pieris Pharmaceuticals, Inc's total revenue sank by 89.1% to $2M since the same quarter in the previous year.
Its net income has dropped by 1767.7% to $-14M since the same quarter in the previous year.
Finally, its free cash flow grew by 7.6% to $-14M since the same quarter in the previous year.
Based on the above factors, Pieris Pharmaceuticals, Inc gets an overall score of 3/5.